HeartSciences (HSCS) vs NeuroOne Medical Technologies (NMTC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
HeartSciences (HSCS) has outperformed NeuroOne Medical Technologies (NMTC) over the past year, losing 18.3% versus a loss of 82.7%. HeartSciences is the larger company by market cap ($14.7 million vs $9.8 million), about 1.5 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HSCS | NMTC |
|---|---|---|
| Share price | $3.04 | $1.08 |
| Market cap | $14.73M | $9.83M |
| 1-day change | -12.89% | -2.70% |
| YTD return | -1.62% | -76.25% |
| 1-year return | -18.28% | -82.69% |
| 5-year return | — | -94.00% |
| EPS (TTM) | $-3.21 | $-0.99 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $5.25 | $6.42 |
| 52-week low | $1.63 | $0.962 |
| Distance from 52-week high | -42.10% | -83.18% |
| Analyst consensus | buy | strong_buy |
| Avg. price target upside | +294.74% | +573.15% |
| Average volume | 154.08K | 339.60K |
| Shares outstanding | 4.84M | 9.11M |
| Employees | 14 | 18 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- HSCS has outperformed NMTC by 64.4 percentage points over the past year.
About HeartSciences
HSCS stock →HeartSciences Inc., a medical technology company, focuses on advancing electrocardiography (ECG) through the integration of artificial intelligence. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional ECG information in the same test; and MyoVista Insights, a cloud-native vendor- and device-agnostic ECG management platform.
Healthcare · Medical Devices · 14 employees
About NeuroOne Medical Technologies
NMTC stock →NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders.
Healthcare · Medical Devices · 18 employees
HSCS vs NMTC FAQ
Which is bigger, HeartSciences or NeuroOne Medical Technologies?
HeartSciences (HSCS) is larger, with a market capitalization of $14.73M compared with $9.83M for NeuroOne Medical Technologies (NMTC).
Which stock has performed better over the past year, HSCS or NMTC?
HSCS returned -18.28% over the past 12 months, compared with -82.69% for NMTC (price return, excluding dividends). Past performance does not predict future results.
Are HeartSciences and NeuroOne Medical Technologies in the same industry?
Yes. Both are classified in the Medical Devices industry within the Healthcare sector.